Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,7,0.95 [0.9-1.01],0.0820389036601873,cis
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,12,0.82 [0.64-1.04],0.101924192214012,cis
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,12,0.93 [0.85-1.02],0.103627043356267,cis
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter XI Diseases of the digestive system,K11_ALCOLIV,Inverse variance weighted,12,0.85 [0.69-1.05],0.134986885733738,cis
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter II Neoplasms,CD2_BENIGN_LEIOMYOMA_UTERI,Inverse variance weighted,12,0.96 [0.91-1.01],0.146600339496299,cis
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter V Mental and behavioural disorders,F5_ALCOHOLAC,Inverse variance weighted,12,0.94 [0.86-1.02],0.148662880527636,cis
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter XI Diseases of the digestive system,NAFLD,Inverse variance weighted,12,1.13 [0.95-1.34],0.158569036612694,cis
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter V Mental and behavioural disorders,ALCOHOLMENTAL,Inverse variance weighted,7,0.95 [0.84-1.09],0.474867193529056,cis
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter IX Diseases of the circulatory system,I9_HYPTENSPOR,Inverse variance weighted,7,1.07 [0.82-1.39],0.614180265622952,cis
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,12,0.98 [0.91-1.06],0.631110877257884,cis
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter V Mental and behavioural disorders,AUD,Inverse variance weighted,12,0.98 [0.92-1.05],0.644130917006586,cis
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,12,0.99 [0.95-1.04],0.67960887273111,cis
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,12,0.97 [0.8-1.16],0.702325166884596,cis
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_BCKGRND_RETINA,Inverse variance weighted,7,1.03 [0.87-1.22],0.708525618790615,cis
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,12,1.01 [0.97-1.04],0.73875840103902,cis
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,12,1 [0.97-1.03],0.805815254753533,cis
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,12,1.01 [0.91-1.13],0.808116595673607,cis
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter V Mental and behavioural disorders,F5_ALCOHOL_DEPENDENCE,Inverse variance weighted,12,0.99 [0.91-1.08],0.827556972494379,cis
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,12,0.98 [0.75-1.29],0.911139859215486,cis
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,12,1 [0.89-1.11],0.945327016067666,cis
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter V Mental and behavioural disorders,AUD,Inverse variance weighted,2,2.06 [1.41-3],0.000163181094373475,trans
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter V Mental and behavioural disorders,F5_ALCOHOL_DEPENDENCE,Inverse variance weighted,2,2.81 [1.58-5],0.000419361661553579,trans
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter V Mental and behavioural disorders,F5_ALCOHOLAC,Inverse variance weighted,2,2.25 [1.38-3.67],0.00112787405587307,trans
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,2,1.85 [1.11-3.09],0.0178851635290346,trans
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,2,2.28 [0.97-5.32],0.0575119048776518,trans
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,2,1.55 [0.96-2.49],0.0718429614473388,trans
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,2,1.56 [0.91-2.67],0.10497989789711,trans
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,2,1.34 [0.86-2.1],0.199873502219283,trans
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter II Neoplasms,CD2_BENIGN_LEIOMYOMA_UTERI,Inverse variance weighted,2,1.19 [0.9-1.59],0.226256890734155,trans
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter XI Diseases of the digestive system,K11_ALCOLIV,Inverse variance weighted,2,1.61 [0.68-3.81],0.28153065754985,trans
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,2,0.68 [0.07-6.44],0.733174874916967,trans
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,2,1.22 [0.33-4.5],0.763887988590263,trans
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,2,1.16 [0.28-4.77],0.840592194439297,trans
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,2,1.31 [0.06-28.09],0.862950134724424,trans
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,2,1.12 [0.3-4.24],0.868858094400132,trans
NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Chapter XI Diseases of the digestive system,NAFLD,Inverse variance weighted,2,1.1 [0.15-7.95],0.923091453880331,trans
